Phosphodiesterase-5 inhibitors for male erectile dysfunction -
Z Sui - etp, 2003 - Expert Opinion
... for MED treat- ment, many of these compounds are scientifically capable of becoming
drugs for MED, as evidenced by the recent launches of vardenafil (Levitra ...
Phosphodiesterase-5 inhibitors for male erectile dysfunction
M Focus, I Biologicals, D Delivery - Expert Opin. Ther. Patents, 2003 - Expert Opinion
... for MED treat- ment, many of these compounds are scientifically capable of becoming
drugs for MED, as evidenced by the recent launches of vardenafil (Levitra ...
-
AUTHOR AND EDITOR INFORMATION
UA Blackstock - emedicine.com
... negative LR = 0.33; 95% CI, 0.23-0.48 ... and decrease in symptoms from heart failure. ...
vasodilators (eg, sildenafil [Viagra], vardenafil [Levitra]), especially when ...
-
13 PDE11
K Omori, J Kotera - Cyclic Nucleotide Phosphodiesterases in Health and Disease, 2006 - books.google.com
... Viagra, Pfizer Inc., New York, NY), vardenafil (Levitra, Bayer AG ... N/A N/A N/A
3.8?0.75 3.15?0.23 N/A ... to be absent in the bladder, colon, heart, small intestine ...
-
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus (Review) -
M Vardi, A Nini - doi.wiley.com
... The introduction of sildenafil (Viagra), vardenafil (Levitra) and tadalafil
(Cialis), have altered the management of erectile dysfunction. ...
-
Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors -
W Jiang, VC Alford, Y Qiu, S Bhattacharjee, TM … - Bioorganic & Medicinal Chemistry, 2004 - Elsevier
... 6] such as recently launched Levitra? (vardenafil) [5 ... 5, and 6 were isolated from
human heart, corpus cavernosum ... of KOtBu was neutralized by HCl (0.23 mL, 2.0 M ...
AUTHOR AND EDITOR INFORMATION -
F Dangond - emedicine.com
... in the EDSS of -0.13 compared with placebo (0.23), an ambulation ... dysfunction -
Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), alprostadil (Muse ...
-
A quantitative approach to probe the dependence and correlation of food-effect with aqueous … -
BN Singh - Drug Dev. Res, 2005 - doi.wiley.com
... within which a drug is not expected to be significantly affected by food falls between
0.148?89.39 mg/ml for aqueous solubility and between 0.23?624 ml for ...
The Partiality of Humanitarian Assistance: Kosovo in Comparative Perspective
T Porter - Journal of Humanitarian Assistance, 2000 - jha.ac
... suffering be reconciled with the principle of universality that lies at the heart
of the ... been a steady decline over the past decade to a figure of 0.23% in 1998 ...
Structural and Functional Features in Human PDE5A1 Regulatory Domain That Provide for Allosteric … -
R Zoraghi, EP Bessay, JD Corbin, SH Francis - Journal of Biological Chemistry, 2005 - ASBMB
... PDE5 is the target of sildenafil (Viagra TM ), tadalafil (Cialis TM ), and vardenafil
(Levitra TM ), all of which are in use for treatment of maladies ...
Source: Google Scholar |